-+ 0.00%
-+ 0.00%
-+ 0.00%

Hunan High-Tech Industry Investment chair Li Aidong visits Tianjin Pharma for operations review

PUBT·08/10/2026 16:09:50
Listen to the news
Hunan High-Tech Industry Investment chair Li Aidong visits Tianjin Pharma for operations review
  • Hunan Pharmaceutical Development Private Equity Fund Management chair Li Aidong visited portfolio company Tianjin Pharmaceutical on Aug. 7, 2026 for an operational review.
  • Management discussed 2026 performance and its “15th Five-Year Plan” strategy, highlighting capacity ramp-up, standardized manufacturing, quality controls.
  • Li urged faster execution to close operational gaps, push reforms, strengthen core technology, build brands, expand sales channels, meet annual targets.
  • The fund manager pledged support for Tianjin Pharmaceutical in R&D, market expansion, restructuring to accelerate growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunan Pharmaceutical Development Private Equity Fund Management Co Ltd published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.